2011-Irbesartan in Patients with Atrial Fibrillation

2011-Irbesartan in Patients with Atrial Fibrillation

ID:40021720

大小:776.03 KB

页数:11页

时间:2019-07-17

2011-Irbesartan in Patients with Atrial Fibrillation_第1页
2011-Irbesartan in Patients with Atrial Fibrillation_第2页
2011-Irbesartan in Patients with Atrial Fibrillation_第3页
2011-Irbesartan in Patients with Atrial Fibrillation_第4页
2011-Irbesartan in Patients with Atrial Fibrillation_第5页
资源描述:

《2011-Irbesartan in Patients with Atrial Fibrillation》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库

1、ThenewenglandjournalofmedicineoriginalarticleIrbesartaninPatientswithAtrialFibrillationTheACTIVEIInvestigators*AbstractBackgroundThemembersofthewritinggroup(SalimTheriskofcardiovasculareventsamongpatientswithatrialfibrillationishigh.Yusuf,M.B.,B.S.,D.Phil.,JeffS.Healey,Weevaluatedwhe

2、therirbesartan,anangiotensin-receptorblocker,wouldreduceM.D.,JanicePogue,M.Sc.,SusanChro-thisrisk.lavicius,R.N.,MarcusFlather,M.B.,B.Ch.,RobertG.Hart,M.D.,StefanH.Hohn-loser,M.D.,CampbellD.Joyner,M.D.,MethodsMarcA.Pfeffer,M.D.,andStuartJ.Con-Werandomlyassignedpatientswithahistoryofri

3、skfactorsforstrokeandasystolicnolly,M.D.),assumeresponsibilityfortheoverallcontentandintegrityofthearti-bloodpressureofatleast110mmHgtoreceiveeitherirbesartanatatargetdoseofcle.AddressreprintrequeststoDr.Yusuf300mgoncedailyordouble-blindplacebo.Thesepatientswerealreadyenrolledinatthe

4、PopulationHealthResearchInsti-oneoftwotrials(ofclopidogrelplusaspirinversusaspirinaloneorversusoralanti-tute,DavidBraleyCardiac,VascularandStrokeResearchInstitute,HamiltonHealthcoagulants).Thefirstcoprimaryoutcomewasstroke,myocardialinfarction,ordeathSciencesandMcMasterUniversity,237

5、fromvascularcauses;thesecondwasthiscompositeoutcomeplushospitalizationBartonSt.East,Hamilton,ONL8L2X2,forheartfailure.Canada,oratyusufs@mcmaster.ca.*TheAtrialFibrillationClopidogrelTrialResultswithIrbesartanforPreventionofVascu-Atotalof9016patientswereenrolledandfollowedforameanof4.1

6、years.ThemeanlarEvents(ACTIVEI)investigatorsarelistedintheSupplementaryAppendix,reductioninsystolicbloodpressurewas2.9mmHggreaterintheirbesartangroupavailableatNEJM.org.Theaffiliationsthanintheplacebogroup,andthemeanreductionindiastolicbloodpressurewasofthewritinggrouparelistedinthe1

7、.9mmHggreater.Thefirstcoprimaryoutcomeoccurredatarateof5.4%perAppendix.100person-yearsinbothgroups(hazardratiowithirbesartan,0.99;95%confi-NEnglJMed2011;364:928-38.denceinterval[CI],0.91to1.08;P=0.85).ThesecondcoprimaryoutcomeoccurredCopyright©2011MassachusettsMedicalSociety.atarateo

8、f7.3%per100p

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。